ClinicalTrials.gg
Not yet recruitingNCT07561606Updated May 1, 2026

Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea

An observational study in Crossbite Teeth, sponsored by October University for Modern Sciences and Arts. Not yet recruiting. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by October University for Modern Sciences and Arts · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
420
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea

Read the detailed description

Understanding the correlation between posterior crossbite and OSA risk is essential for early detection and prevention. Pediatric dentists and orthodontists are uniquely positioned to identify craniofacial risk factors and initiate early intervention.

Screening tools such as OSA-18 can help identify children at risk and facilitate timely referral for multidisciplinary management. Furthermore, evaluating this association will contribute to improving clinical decision-making and patient outcomes.

Aim of study:

To assess the correlation between posterior crossbite and the risk of obstructive sleep apnea in children using the OSA-18 questionnaire.

02

Conditions studied

  • Crossbite Teeth
03

In context

Lead sponsor

October University for Modern Sciences and Arts is the lead sponsor of 52 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Children with posterior crossbite Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children in mixed dentition stage aged 6-12 years
  • Presence of posterior crossbite

Exclusion criteria

Exclusion Criteria:

  • Syndromic patients
  • Previous orthodontic treatment
  • Chronic respiratory or neurological disorders Matching criteria and allocation ratio
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
420 participants (estimated)
Patient registry
No

Groups and cohorts

  • intervention

    Screening using the OSA-18 (Obstructive Sleep Apnea-18) questionnaire

    Other: Interventions

  • comparator

    Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups

    Other: Comparator

Interventions

  • OtherComparator

    Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups

  • OtherInterventions

    Screening using the OSA-18 (Obstructive Sleep Apnea-18) questionnaire

06

What researchers measure

Primary outcomes

  1. Risk or presence of obstructive sleep apnea (OSA) based on OSA-18 scores

    questionnaire

    Time frame: 2 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Jun 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2026
First posted
May 1, 2026
StartEst.
Apr 2026
Primary completionEst.
Jun 2026
CompletionEst.
Jun 2026
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07561606
Lead sponsor
October University for Modern Sciences and Arts
Responsible party
Marwa Ahmed Salmoon (Lecturer, October University for Modern Sciences and Arts) — Principal investigator
First posted
May 1, 2026
Start date
Apr 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
May 1, 2026

Study contacts

Marwa A. Salmoon, Ph.D
Contact
maasalmoon@msa.edu.eg
01016555055
Sally M Mosallam, Master Degree
study director · MSA University
Ahmed Ayman
principal investigator · MSA University
Mohamed Hesham
principal investigator · MSA University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion